An Italian survey on the use of hypertonic solution in aerosol

An Italian survey on the use of hypertonic solution in aerosol

Authors

  • M. Ros Cystic Fibrosis Center Pediatric Unit, Ospedale Ca’ Foncello, Treviso, Italy
  • F. Lucca Women’s and children’s Department University of Padova, Italy

Keywords:

hypertonic saline, cystic fibrosis, hyaluronan, inhaled therapy

Abstract

Hypertonic saline (HS) preceded by a bronchodilator is an inexpensive, safe, and effective additional therapy for patients with cystic fibrosis. A questionnaire composed of 14 closed-ended questions was prepared and sent by email to the Directors of 30 Italian CF Centers for verifying which the indications in CF patients of inhaled HS and HS with hyaluronan (HSHA) are, how tolerability to HSHA is assessed and how compliance and tolerability to HSHA is evaluated.

Downloads

Issue

Vol. 85 No. 4 (2014): Supplement: Inhalation therapy in cystic fibrosis

Section

ORIGINAL ARTICLES

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Ros M, Lucca F. An Italian survey on the use of hypertonic solution in aerosol. Acta Biomed [Internet]. 2014 Dec. 9 [cited 2024 Jul. 27];85(4):19-21. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/4083